IL17A and hepatocellular carcinoma: In mouse models, inhibition of IL-17 signaling reduced alcohol-induced HCC progression by suppressing PPARγ/PGC1-dependent cholesterol synthesis (Ma et al., 2020; Zhang et al., 2022b).